Actipulse Neuroscience
YC W22Boston, US · Founded 2017 · 38 employees · 2 known investors
Actipulse Neuroscience develops non-invasive brain stimulation technologies using high-frequency magnetic pulses to treat central nervous system disorders, including major depressive disorder and neurodegenerative diseases. The company conducts clinical research on transcranial neuromodulation devices.
BiotechDigital HealthHealthtechMedical DevicesMental Health TechNeurotechnologyin /actipulse-international@neuro_gabo
Founders & leadership· Y Combinator alumni (W22)
Adrien ChâtilloninFounder
Gabriel Villafuertein𝕏Founder
Investors · 2
In the news
- Actipulse Neuroscience Nominated for Best Medical Startup at the 2024 Prix Galien | AP Newsapnews.com · 2024
- Innovative treatments: the new frontier for mental healthdrugtargetreview.com · 2022
- Y Combinator grants funding to neuro-tech startup working to improve mental healthcare accessibility - StartUp Beatstartupbeat.com · 2022
- Esta startup quiere llevar su tecnología de neuroestimulación a la casa de sus pacientesforbes.com.mx · 2022
- Adrien Châtillon, CEO de Actipulse Neuroscience: “América Latina es una región que consume salud, pero no innova” | AméricaEconomía | AméricaEconomíaamericaeconomia.com · 2022
- Actipulse Neuroscience on Republic 2021 - Kingscrowdkingscrowd.com · 2021
- Actipulse Neuroscience - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Actipulse Neuroscience - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021